194 related articles for article (PubMed ID: 26309522)
1. Overexpression of vascular endothelial growth factor indicates poor outcomes of glioma: a systematic review and meta-analysis.
Chen W; He D; Li Z; Zhang X; Pan D; Chen G
Int J Clin Exp Med; 2015; 8(6):8709-19. PubMed ID: 26309522
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 is a valuable prognostic factor in gliomas: evidence from a systematic review and meta-analysis.
Chen WJ; He DS; Tang RX; Ren FH; Chen G
Asian Pac J Cancer Prev; 2015; 16(2):411-20. PubMed ID: 25684464
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis.
Yu L; Deng L; Li J; Zhang Y; Hu L
Gynecol Oncol; 2013 Feb; 128(2):391-6. PubMed ID: 23142075
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
5. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
Wu B; Sun C; Feng F; Ge M; Xia L
J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
[TBL] [Abstract][Full Text] [Related]
6. A Meta-Analysis of Vascular Endothelial Growth Factor for Nasopharyngeal Cancer Prognosis.
Wang F; Peng L; Wang Y; Liu X
Front Oncol; 2018; 8():486. PubMed ID: 30430078
[No Abstract] [Full Text] [Related]
7. Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.
Luo Y; Ren F; Liu Y; Shi Z; Tan Z; Xiong H; Dang Y; Chen G
Int J Clin Exp Med; 2015; 8(7):10235-47. PubMed ID: 26379815
[TBL] [Abstract][Full Text] [Related]
8. Correlation of vascular endothelial growth factor with survival and pathological characteristics of patients with osteosarcoma: A systematic review and meta-analysis.
Xin S; Wei G
Eur J Cancer Care (Engl); 2022 Sep; 31(5):e13629. PubMed ID: 35707976
[TBL] [Abstract][Full Text] [Related]
9. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysis.
Zhan P; Qian Q; Yu LK
Hepatobiliary Surg Nutr; 2013 Jun; 2(3):148-55. PubMed ID: 24570933
[TBL] [Abstract][Full Text] [Related]
11. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer.
Wagner AD; Thomssen C; Haerting J; Unverzagt S
Cochrane Database Syst Rev; 2012 Jul; (7):CD008941. PubMed ID: 22786517
[TBL] [Abstract][Full Text] [Related]
12. Predictive role of the overexpression for CXCR4, C-Met, and VEGF-C among breast cancer patients: A meta-analysis.
Wang F; Li S; Zhao Y; Yang K; Chen M; Niu H; Yang J; Luo Y; Tang W; Sheng M
Breast; 2016 Aug; 28():45-53. PubMed ID: 27214240
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of vascular endothelial growth factor in cervical cancer: a meta-analysis.
Zhang J; Liu J; Zhu C; He J; Chen J; Liang Y; Yang F; Wu X; Ma X
Oncotarget; 2017 Apr; 8(15):24797-24803. PubMed ID: 28177889
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of vascular endothelial growth factor in patients with head and neck cancer: A meta-analysis.
Zang J; Li C; Zhao LN; Shi M; Zhou YC; Wang JH; Li X
Head Neck; 2013 Oct; 35(10):1507-14. PubMed ID: 22987573
[TBL] [Abstract][Full Text] [Related]
16. 3D-ASL perfusion correlates with VEGF expression and overall survival in glioma patients: Comparison of quantitative perfusion and pathology on accurate spatial location-matched basis.
Pang H; Dang X; Ren Y; Zhuang D; Qiu T; Chen H; Zhang J; Ma N; Li G; Zhang J; Wu J; Feng X
J Magn Reson Imaging; 2019 Jul; 50(1):209-220. PubMed ID: 30652410
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of vascular endothelial growth factor in patients with renal cell carcinoma: a systematic review of the literature and meta-analysis.
Shen H; Liu Q; Li M; Yang P
Clin Invest Med; 2017 Apr; 40(2):E40-E48. PubMed ID: 28447576
[TBL] [Abstract][Full Text] [Related]
18. EZH2 overexpression is associated with poor prognosis in patients with glioma.
Zhang Y; Yu X; Chen L; Zhang Z; Feng S
Oncotarget; 2017 Jan; 8(1):565-573. PubMed ID: 27880940
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of vascular endothelial growth factor expression in women with ovarian cancer: A meta-analysis.
Hui G; Meng M
J BUON; 2015; 20(3):870-8. PubMed ID: 26214642
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of vascular endothelial growth factor expression in patients with prostate cancer: a systematic review with meta-analysis.
Wang K; Peng HL; Li LK
Asian Pac J Cancer Prev; 2012; 13(11):5665-9. PubMed ID: 23317235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
